Lumicera and Costco Partner to Offer Cost-Plus Specialty Pharmacy with Enhanced Pricing and Patient Support In a move poised to shake up the specialty pharmacy market, Lumicera Health Services, a nationally recognized provider of specialty pharmacy solutions, has announced a…
Debiopharm and Oncodesign Services Partner to Advance Radiopharmaceuticals in Preclinical Research Debiopharm Research & Manufacturing S.A. (Debiopharm), a privately held, Swiss-based global biopharmaceutical company committed to advancing the treatment landscape for cancer and infectious diseases, has announced a strategic licensing…
CN Bio and Pharmaron Forge Long-Term Global Partnership for OOC Tech Development In a significant stride toward revolutionizing preclinical drug development, CN Bio, a leading innovator in Organ-on-a-Chip (OOC) technologies, has entered into a strategic partnership with Pharmaron, one of…
FDA Grants Breakthrough Status to BrainChild Bio’s CAR T Therapy for Pediatric Brain Tumors BrainChild Bio, Inc., a clinical-stage biotechnology company at the forefront of neuro-oncology cell therapy innovation, has achieved a significant regulatory milestone with the announcement that its…
Secretome Therapeutics Names Dr. Marshelle Smith Warren as New Chief Medical Officer Secretome Therapeutics, a pioneering clinical-stage biotechnology company dedicated to advancing therapies derived from neonatal cardiac progenitor cells (nCPCs), is pleased to announce the appointment of Marshelle Smith Warren,…
Biostate AI and Weill Cornell Join Forces to Harness AI for Tailored Leukemia Therapies In a groundbreaking move that combines the power of artificial intelligence (AI) with cutting-edge medical research, Biostate AI, a leader in artificial intelligence-driven RNA sequencing, has…
ATCC Expands Leadership Team Through Senior Executive Appointments In a move that underscores its commitment to advancing science and strengthening operational excellence, ATCC, the global leader in biological materials management and standards, has announced a series of pivotal leadership appointments…
Africa CDC and WHO Revise Mpox Strategy Amid Ongoing Outbreaks In a significant development aimed at containing the ongoing mpox outbreak, the Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO) have jointly revised…
PharmaJet Highlights Partner Data Showing Enhanced Immune Response with Needle-Free Vaccine Delivery PharmaJet, a medical technology company pioneering innovative approaches to injectable drug delivery, will unveil compelling new data from ongoing DNA cancer vaccine trials utilizing its proprietary needle-free injection…
Rigaku Partners with Spera Pharma to Advance Drug Development In a move poised to reshape the landscape of drug discovery and pharmaceutical development, Rigaku Corporation—a leading scientific instrumentation manufacturer—and SPERA PHARMA, Inc., a cutting-edge contract development and manufacturing organization (CDMO)—have…
EveryONE Medicines Names Michelle L. Mellion, MD, as New Chief Medical Officer EveryONE Medicines, a trailblazing biotech company transforming the way individualized therapies are developed for children suffering from ultra-rare and life-threatening neurodegenerative diseases, has announced the appointment of Michelle…
ACIP Backs Pfizer’s RSV Vaccine ABRYSVO for At-Risk Adults Aged 50–59 Pfizer Inc. (NYSE: PFE) has taken a significant step forward in the effort to combat respiratory syncytial virus (RSV) infections among U.S. adults, as the U.S. Centers for Disease…
